Dr. Betty Lee has many years experience on biosecurity and non-proliferation issues. She was a Biosecurity Fellow of the Johns Hopkins Health Security Center and participated in the SynBiobeta 2018 Conference with more than twenty-five international fellows chosen from a competitive program. She educates industries and academia on dual use technology and participates in outreach. She organized the first Emerging Technologies-Brain Computer Interface (BCI) Conference in 2023 for industry and government representatives. She is knowledgeable on non-proliferation issues of bioweapons. Dr. Lee participates as a judge for the International Genetically Engineered Machine (iGEM) jamboree on an annual basis. In addition, she participated in the policy review of “Optimizing the Security of Biological Select Agents and Toxins in the United States” in 2010. She has a PhD from Dartmouth Medical School, USA, M.S. Clinical Chemistry from the University of Windsor, Canada and M.S. Biochemistry from LSU Medical Center, USA. Dr. Lee completed her postdoctoral training at the National Institutes of Health.